Modern Finance Online
SEE OTHER BRANDS

Your top news on finance and banking

Modern Finance Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Finance Online.

Press releases published on March 6, 2025

New study links sports gambling with alcohol-related risks over time

New study links sports gambling with alcohol-related risks over time

Las Vegas, NV 89109, March 06, 2025 (GLOBE NEWSWIRE) -- A new longitudinal study published in JAMA Psychiatry finds that sports gambling frequency and alcohol-related problems are strongly associated over time, reinforcing concerns about the potential …

CytomX Therapeutics Announces 2024 Financial Results and Provides Business Update

CytomX Therapeutics Announces 2024 Financial Results and Provides Business Update

- Continued progress with lead program, CX-2051 (EpCAM PROBODY® Topo-1 ADC), in Phase 1a study in advanced colorectal cancer with initial Phase 1a clinical data to be presented in 1H 2025 - - CX-801 (PROBODY® Interferon-alpha 2b) Phase 1a translational …

TerrAscend Reports Fourth Quarter and Full Year 2024 Financial Results

TerrAscend Reports Fourth Quarter and Full Year 2024 Financial Results

Fourth Quarter Net Revenue of $74.4 million, up 0.3% from $74.2 million in the third quarter of 2024 Fourth Quarter Gross Profit Margin of 50.2%, up 140 basis points from 48.8% in the third quarter of 2024 Full Year 2024 Net Cash provided by continuing …

Theriva™ Biologics Reports Full-Year 2024 Operational Highlights and Financial Results

Theriva™ Biologics Reports Full-Year 2024 Operational Highlights and Financial Results

– Enrollment completed in VIRAGE Phase 2b clinical trial of VCN-01 in metastatic pancreatic ductal adenocarcinoma (PDAC); topline data expected in Q2 2025 – – VCN-01 development bolstered by FDA award of Fast Track designation for the treatment of PDAC and …

Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to March 9, 2025

Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to March 9, 2025

New York, NY, March 06, 2025 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (OTC Pink: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink” or the “Company”), a special purpose acquisition company, announced today that on March 6, 2025, it caused to be deposited $60,000 …

Oruka Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Oruka Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

ORKA-001, targeting IL-23p19, Phase 1 trial ongoing, with pharmacokinetic (PK) data expected in 2H 2025 ORKA-001 Phase 2a initiation expected in 2H 2025, with efficacy readout in 2H 2026 that provides multiple opportunities to show differentiation over …

Hummingbird Resources PLC Files Early Warning Report

Hummingbird Resources PLC Files Early Warning Report

LONDON, March 06, 2025 (GLOBE NEWSWIRE) -- Hummingbird Resources PLC (“Hummingbird”), a West African gold mining company, announced today that in connection with the implementation of a take-over of Hummingbird pursuant to the UK Takeover Code (the “Code …

Foghorn Therapeutics Provides Financial Update for 2024 and 2025 Strategic Outlook

Foghorn Therapeutics Provides Financial Update for 2024 and 2025 Strategic Outlook

First-in-class oral selective SMARCA2 (BRM) inhibitor FHD-909 (LY4050784) continues enrollment in Phase 1 trial for SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population FHD-909 preclinical combination …

Jushi Holdings Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Jushi Holdings Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Full Year 2024 Net Loss of $48.8 Million Compared to Net Loss of $65.1 Million in 2023 Full Year 2024 Adjusted EBITDA of $46.2 Million Compared to $40.8 Million in 2023 Increased Quarterly and Annual Operational Cash Flow Compared to Prior Periods to $7.2 …

Barnes & Noble Education Strengthens Leadership Team with the Appointment of Christopher Neumann as General Counsel & Corporate Secretary and Gary Luster as Chief Accounting Officer

Barnes & Noble Education Strengthens Leadership Team with the Appointment of Christopher Neumann as General Counsel & Corporate Secretary and Gary Luster as Chief Accounting Officer

BASKING RIDGE, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- Barnes …

NextCure Provides Business Update and Reports Full Year 2024 Financial Results

NextCure Provides Business Update and Reports Full Year 2024 Financial Results

Completed cohort 1 of the Phase 1 trial of LNCB74 (B7-H4 ADC) in multiple cancers in February 2025 and plan to initiate backfill cohorts in the second half of 2025 Cash of approximately $68.6 million expected to fund operations into the second half of 2026 …

Five Star Bank Appoints Eric Marks Chief Consumer Banking Officer

Five Star Bank Appoints Eric Marks Chief Consumer Banking Officer

WARSAW, N.Y., March 06, 2025 (GLOBE NEWSWIRE) -- Financial Institutions, Inc. (NASDAQ: FISI), parent company of Five Star Bank (“Five Star” or the “Bank”) and Courier Capital, LLC, announced that Eric W. Marks has joined as Senior Vice President, Chief …

Elutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-Out

Elutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-Out

– Overall BioEnvelope sales up 18%, with same-center sales increasing 65% following EluPro commercialization – SILVER SPRING, Md., March 06, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting …

El Pollo Loco Holdings, Inc. Announces Fourth Quarter 2024 Financial Results

El Pollo Loco Holdings, Inc. Announces Fourth Quarter 2024 Financial Results

COSTA MESA, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- El Pollo Loco Holdings, Inc. (Nasdaq: LOCO) today announced financial results for the 13- and 52-week periods ended December 25, 2024. Highlights for the fourth quarter ended December 25, 2024 compared …

Fidus Investment Corporation Announces Fourth Quarter and Full Year 2024 Financial Results

Fidus Investment Corporation Announces Fourth Quarter and Full Year 2024 Financial Results

Board of Directors Declared Total Dividends of $0.54 per Share for First Quarter 2025 Base Dividend of $0.43 and Supplemental Dividend of $0.11 Per Share EVANSTON, Ill, March 06, 2025 (GLOBE NEWSWIRE) -- Fidus Investment Corporation (NASDAQ:FDUS) (“Fidus” …

Hudson Technologies Reports Fourth Quarter and Year End 2024 Results

Hudson Technologies Reports Fourth Quarter and Year End 2024 Results

Strong unlevered balance sheet with $70.1 million in cash and no debt Repurchased $8.1 million of common stock in 2024 Increased refrigerant reclamation volume by 18% in 2024 WOODCLIFF LAKE, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- Hudson Technologies, Inc …

Noodles & Company Announces Fourth Quarter and Full Year 2024 Financial Results

Noodles & Company Announces Fourth Quarter and Full Year 2024 Financial Results

BROOMFIELD, Colo., March 06, 2025 (GLOBE NEWSWIRE) -- Noodles …

FormFactor Partners with Delft Circuits to Revolutionize Quantum Computing Interfacing

FormFactor Partners with Delft Circuits to Revolutionize Quantum Computing Interfacing

LIVERMORE, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- FormFactor, Inc. (NASDAQ: FORM), a leader in precision test and measurement solutions, and Delft Circuits, an innovator in high-density cryogenic cabling solutions, have teamed up to integrate Delft …

Reliance Global Group Reports 2024 Results and Provides Business Update

Reliance Global Group Reports 2024 Results and Provides Business Update

LAKEWOOD, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: RELI) (“Reliance”, “we” or the “Company”) today provided a business update and reported financial results for the year ended December 31, 2024. “We are pleased to …

Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Successful End-of-Phase 2 Meeting with FDA and Alignment on Phase 3 Program for Hepatitis C Virus (HCV) Patient Enrollment in Global Phase 3 HCV Program Expected to Start in April 2025 Conference Call at 4:30 pm ET Today BOSTON, March 06, 2025 (GLOBE …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service